HIV drug resistance in the era of antiretroviral therapy expansion: the hidden cost of success
The Lancet Microbe · 2026-06 · 7 (6) · 101391
DOI: 10.1016/j.lanmic.2026.101391 ↗Kurz gefasst
Leserbrief in der Zeitschrift The Lancet Microbe, 2026-06. Verfasst von Shengshan Xu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Jiangmen Central Hospital, Jiangmen 529030, Guangdong, China. Electronic address: xushengshan97@163.com. Die Arbeit nennt 3 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
We read with great interest the Article by Michael A Martin and colleagues,1 published in The Lancet Microbe, wherein the authors elucidated the dynamics of HIV drug resistance during the scale-up of antiretroviral therapy in Uganda. The finding that the overall population prevalence of drug-resistant viraemia declined despite rising pretreatment resistance represents a public health triumph. However, we caution that this population-level success might obscure critical individual-level risks that could undermine the sustainability of current first-line regimens, particularly in the context of dolutegravir roll-out.
Autor:innen und Institutionen
- Department of Thoracic Surgery, Jiangmen Central Hospital, Jiangmen 529030, Guangdong, China. Electronic address: xushengshan97@163.com.
- Department of Thoracic Surgery, Jiangmen Central Hospital, Jiangmen 529030, Guangdong, China.
Zitieren
APA
Xu, S., Lin, Z., & Lu, Z. (2026). HIV drug resistance in the era of antiretroviral therapy expansion: the hidden cost of success. The Lancet Microbe, 7(6), 101391. https://doi.org/10.1016/j.lanmic.2026.101391
Vancouver
Xu S, Lin Z, Lu Z. HIV drug resistance in the era of antiretroviral therapy expansion: the hidden cost of success. The Lancet Microbe. 2026;7(6):101391. doi:10.1016/j.lanmic.2026.101391
BibTeX
@article{Xu2026,
author = {Xu, Shengshan and Lin, Zhichao and Lu, Zhuming},
title = {HIV drug resistance in the era of antiretroviral therapy expansion: the hidden cost of success},
journal = {The Lancet Microbe},
year = {2026},
volume = {7},
number = {6},
pages = {101391},
doi = {10.1016/j.lanmic.2026.101391}
}
EUVIMED